Harry H. Mansbach

4.2k total citations
21 papers, 983 citations indexed

About

Harry H. Mansbach is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Harry H. Mansbach has authored 21 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Harry H. Mansbach's work include Prostate Cancer Treatment and Research (11 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Acute Ischemic Stroke Management (5 papers). Harry H. Mansbach is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Acute Ischemic Stroke Management (5 papers). Harry H. Mansbach collaborates with scholars based in United States, Belgium and Netherlands. Harry H. Mansbach's co-authors include L D'Olhaberriague, Paul Shin, Irene Litvan, Virinder Nohria, Susan T. Hall, Panayiotis Mitsias, Cheolsu Shin, James O. McNamara, Jacqueline A. French and Robert Leroy and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Stroke.

In The Last Decade

Harry H. Mansbach

21 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry H. Mansbach United States 10 310 276 258 248 187 21 983
E. Bottacchi Italy 21 156 0.5× 160 0.6× 233 0.9× 327 1.3× 256 1.4× 49 1.5k
A. Molins Spain 21 330 1.1× 494 1.8× 366 1.4× 268 1.1× 125 0.7× 49 1.6k
H. J. Gelmers Netherlands 17 131 0.4× 178 0.6× 155 0.6× 265 1.1× 139 0.7× 37 1.1k
Sara Shams Sweden 24 153 0.5× 332 1.2× 139 0.5× 288 1.2× 112 0.6× 55 1.4k
Hermann Neugebauer Germany 19 141 0.5× 141 0.5× 161 0.6× 420 1.7× 190 1.0× 65 1.2k
Agnieszka Słowik Poland 21 232 0.7× 141 0.5× 68 0.3× 388 1.6× 199 1.1× 90 1.3k
Camilla Steen Jensen Denmark 19 111 0.4× 136 0.5× 138 0.5× 131 0.5× 214 1.1× 30 1.0k
Felix Fluri Switzerland 20 449 1.4× 99 0.4× 140 0.5× 466 1.9× 238 1.3× 53 1.3k
Sabrina Schilling France 10 290 0.9× 167 0.6× 106 0.4× 281 1.1× 52 0.3× 10 955
Xiaoming Rong China 23 475 1.5× 118 0.4× 65 0.3× 241 1.0× 271 1.4× 79 1.6k

Countries citing papers authored by Harry H. Mansbach

Since Specialization
Citations

This map shows the geographic impact of Harry H. Mansbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry H. Mansbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry H. Mansbach more than expected).

Fields of papers citing papers by Harry H. Mansbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry H. Mansbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry H. Mansbach. The network helps show where Harry H. Mansbach may publish in the future.

Co-authorship network of co-authors of Harry H. Mansbach

This figure shows the co-authorship network connecting the top 25 collaborators of Harry H. Mansbach. A scholar is included among the top collaborators of Harry H. Mansbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry H. Mansbach. Harry H. Mansbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beer, Tomasz M., Andrew J. Armstrong, Cora N. Sternberg, et al.. (2015). Enzalutamide (ENZA) in men with chemotherapy-Naïve metastatic castration-resistant prostate cancer (mCRPC): Final analysis of the phase 3 PREVAIL study.. Journal of Clinical Oncology. 33(15_suppl). 5036–5036. 10 indexed citations
2.
3.
Kimura, Go, Junji Yonese, Takashi Fukagai, et al.. (2015). Subgroup analyses of Japanese patients from the PREVAIL trial of enzalutamide (ENZA) in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 33(7_suppl). 265–265. 2 indexed citations
4.
5.
Graff, Julie N., Giulia Baciarello, Andrew J. Armstrong, et al.. (2015). Clinical outcomes and safety in men ≥ 75 and < 75 years with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide in the phase 3 PREVAIL trial.. Journal of Clinical Oncology. 33(7_suppl). 200–200. 3 indexed citations
6.
Higano, Celestia S., Joshi J. Alumkal, S. Chowdhury, et al.. (2014). Response Rates and Outcomes with Enzalutamide for Patients with Metastatic Castration Resistant Prostate Cancer and Visceral Disease in the Prevail Trial. Annals of Oncology. 25. iv262–iv262. 5 indexed citations
7.
Ivanescu, Cristina, D. Phung, Yohann Loriot, et al.. (2014). Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC). Value in Health. 17(7). A650–A651. 1 indexed citations
8.
Morris, Michael J., Yohann Loriot, Tomasz M. Beer, et al.. (2014). Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo.. Journal of Clinical Oncology. 32(15_suppl). 5054–5054. 2 indexed citations
9.
Armstrong, Andrew J., Bertrand Tombal, Cora N. Sternberg, et al.. (2014). Primary, secondary, and quality-of-life endpoint results from PREVAIL, a phase 3 study of enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(15_suppl). 5007–5007. 4 indexed citations
10.
Loriot, Yohann, K. Miller, Cora N. Sternberg, et al.. (2014). Impact of Enzalutamide on Skeletal Related Events (Sres), Pain and Quality of Life (Qol) in the Prevail Trial. Annals of Oncology. 25. iv259–iv259. 3 indexed citations
11.
French, Jacqueline A., Bassel Abou‐Khalil, Robert Leroy, et al.. (2011). Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology. 76(18). 1555–1563. 149 indexed citations
12.
Brodie, Martin J., Holger Lerche, António Gil‐Nagel, et al.. (2010). Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology. 75(20). 1817–1824. 153 indexed citations
13.
Austin, Randall, et al.. (2004). The Sumatriptan/Naratriptan Aggregated Patient (SNAP) Database: Aggregation, Validation and Application. Cephalalgia. 24(7). 586–595. 7 indexed citations
14.
Bruno, Askiel, Joseph P. McConnell, Harry H. Mansbach, et al.. (2002). Aspirin and Urinary 11-Dehydrothromboxane B 2 in African American Stroke Patients. Stroke. 33(1). 57–60. 22 indexed citations
15.
Dayno, Jeffrey M. & Harry H. Mansbach. (1999). Acute stroke units. Journal of Stroke and Cerebrovascular Diseases. 8(3). 160–170. 4 indexed citations
16.
Tanné, David, Vernice Bates, Piero Verro, et al.. (1999). Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey. Neurology. 53(2). 424–424. 145 indexed citations
17.
D'Olhaberriague, L, K.M.A. Welch, Vijaya Nagesh, et al.. (1998). Preliminary clinical–radiological assessment of a MR tissue signature model in human stroke. Journal of the Neurological Sciences. 156(2). 158–166. 8 indexed citations
18.
D'Olhaberriague, L, Irene Litvan, Panayiotis Mitsias, & Harry H. Mansbach. (1996). A Reappraisal of Reliability and Validity Studies in Stroke. Stroke. 27(12). 2331–2336. 145 indexed citations
19.
Simonato, Michele, David A. Hosford, David M. Labiner, et al.. (1991). Differential expression of immediate early genes in the hippocampus in the kindling model of epilepsy. Molecular Brain Research. 11(2). 115–124. 88 indexed citations
20.
King, Peter H., Cheolsu Shin, Harry H. Mansbach, Lan S. Chen, & James O. McNamara. (1987). Microinjection of a benzodiazepine into substantia nigra elevates kindled seizure threshold. Brain Research. 423(1-2). 261–268. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Bottacchi Breakdown of academic impact, for papers by A. Molins Breakdown of academic impact, for papers by H. J. Gelmers Breakdown of academic impact, for papers by Sara Shams Breakdown of academic impact, for papers by Hermann Neugebauer Breakdown of academic impact, for papers by Agnieszka Słowik Breakdown of academic impact, for papers by Camilla Steen Jensen Breakdown of academic impact, for papers by Felix Fluri Breakdown of academic impact, for papers by Sabrina Schilling Breakdown of academic impact, for papers by Xiaoming Rong
Rankless by CCL
2026